Ajinomoto Co., Inc. · TSE:2802
Ajinomoto — Q1 FY2021 Earnings Presentation
11 slides from Ajinomoto's earnings presentation, Jul 30, 2021
Slide 1: Financial Results for Q1 of FY2021 (Ending March 31, 2022)
Ajinomoto Co., Inc. (2802) Financial Results for Q1 of FY2021 (Ending March 31, 2022) Tetsuya Nakano Executive Officer & Vice President July 30, 2021 Note: Business profit (consolidated) in this material: Sales - Cost of sales - Selling expenses, Research & development expenses and General & adminis
Slide 2: I-1. Q1 Results Summary
I-1. Q1 Results Summary FY2021 Q1 Results Summary Sales: ¥276.3 billion (111.5% of FY2020 results; 104.8％ of FY2019 results） Business profit: ¥38.9 billion (115.1% of FY2020 results; 141.0％ of FY2019 results) 1. Sales: Increased (in local currencies: increased) • Sales increased in key segments: Sea
Slide 3: I-2. Sales and Business Profit by Segment
I-2. Sales and Business Profit by Segment Sales increased overall due to increases in key segments. Business profit increased significantly overall due to increased revenue in Bio-Pharma Services & Ingredients and in Functional Materials in Healthcare and Others, despite a decrease in profits in Fro
Slide 4: I-3. Sales and Business Profit by Region (in yen)
I-3. Sales and Business Profit by Region (in yen) Sales: increased in all regions. Sales of Seasonings and Foods increased in all regions, primarily due to recovering sales in foodservice markets. Frozen Foods increased due to restaurant-use products recovering in North America, despite a revenue de
Slide 5: I-4. Each Level of Profit (vs. prev. year)
I-4. Each Level of Profit (vs. prev. year) The first quarter of FY2021 ended with increased sales and profit. The ratio of SGA expenses to sales was kept to a certain level and expenses are in control, despite an increase in SGA expenses due to strategic use of marketing expenses targeting organic g
Slide 6: I-5. Items that Impact Business Results (Updated)
I-5. Items that Impact Business Results (Updated) Impacts on FY2021 business results (macro scenario) At the present time, it cannot be predicted when the COVID-19 outbreak will come to an end, so the economic outlook continues to be uncertain. In these circumstances, the Company has prepared the bu
Slide 7: I-6. Each Level of Profit (progress)
I-6. Each Level of Profit (progress) Sales were in line with standard progress (25%). Business profit and profit attributable to owners of the parent company are on a pace to exceed standard progress. With skyrocketing prices for raw materials and the effect of COVID-19 in the major ASEAN countries,
Slide 8: Reference Material Appendix: Consolidated Results First Quarter Ended June 30, 2021
Reference Material Appendix: Consolidated Results First Quarter Ended June 30, 2021 Note: Business profit (consolidated) in this material: Sales - Cost of sales - Selling expenses, Research & development expenses and General & administrative expenses + Share of profit of associates and joint venture
Slide 9: Sales and Business Profit by Region (in local currency)
Sales and Business Profit by Region (in local currency) FY2021 Q1 Sales and Business Profit by Region vs. Prev. Year (in local currency) Japan Asia Americas EMEA Other Total Sales 104% 108% 116% 111% - 109% Seasonings and Foods 101% 111% 120% 119% - 108% Frozen Foods 99% 88% 111% 169% - 107% Healthc
Slide 10: Sales and Business Profit (vs. FY2019)
Sales and Business Profit (vs. FY2019) Q1-FY21 Q1-FY19 vs. FY19 vs. FY19 (¥ billion) Actual Actual (in local (A)/(B) (A) (B) currency) Sales 276.3 263.7 104% 105% Seasonings and Foods 157.5 152.0 103% 105% Sauce & Seasonings 75.8 69.6 108% Quick Nourishment 44.5 43.9 101% Solution & Ingredients (S&I
Slide 11: Forward-looking statements
Forward-looking statements, such as business performance forecasts, made in these materials are based on management's estimates, assumptions and projections at the time of publication. A number of factors could cause actual results to differ materially from expectations. This material includes summa